TITLE

Stem-cell agency faces budget dilemma

AUTHOR(S)
Check Hayden, Erika
PUB. DATE
February 2012
SOURCE
Nature;2/2/2012, Vol. 482 Issue 7383, p15
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on budget plans for the California Institute for Regenerative Medicine (CIRM) to address the end of its financial support from the state of California by 2021. Topics include the impact of budget shortfalls in California, the cancellation of its only embryonic stem cell clinical trial in 2011, and the uncertainty of federal stem cell funding after 2012. CIRM is looking to a non-profit model of private funding as well as focusing on the clinical applications of its research.
ACCESSION #
70982805

 

Related Articles

  • State stem cell agency floats idea of $70 million 'Alpha' clinics. Dolgin, Elie // Nature Medicine;Jul2013, Vol. 19 Issue 7, p798 

    The article reports on the proposal by the California Institute for Regenerative Medicine (CIRM) to provide 70 million U.S. dollars in funding for a network of so-called Alpha stem cell clinics. This network is said to be aimed at gathering the necessary scientific, technical and medical...

  • City takes cleaver to arts groups' funding. Souccar, Miriam Kreinin // Crain's New York Business;5/17/2010, Vol. 26 Issue 20, p1 

    The article focuses on the impact of proposed budget cuts on the funding of nonprofit art and cultural groups in New York City.

  • Geron Seeks $100M in 'Long-Term' Funding. Wall, Tom // BioWorld Today;12/8/2010, Vol. 21 Issue 236, p1 

    This article reports on the public offering launched by Geron on December 2, 2010 that could raise as much as 100 million U.S. dollars. Proceeds from the offering will be used for clinical trials, clinical development of product candidates and general corporate purposes. A total of 17.4 million...

  • Court paints with broad brush, upends U.S. stem cell policy. Lefkowitz, Jay // Hill;9/16/2010, Vol. 17 Issue 100, p31 

    In this article the author focuses on the court ruling which emphasized the preclusion of an embryonic stem cell research project from receiving federal fundings by the Dickey-Wicker Amendment if one step of the project results in the destruction of an embryo in the U.S.

  • Chief Judge Suspends Funding for Embryonic Stem Cell Research. Bekisz, Jonathan // Penn Bioethics Journal;Fall2010, Vol. 6 Issue 2, p5 

    The article reports on the court decision made by U.S. District Court Chief Judge Royce Lamberth concerning the suspension of the funding for human embryonic stem cell research.

  • US courts throw ES cell research into disarray. Fox, Jeffrey L. // Nature Biotechnology;Oct2010, Vol. 28 Issue 10, p991 

    This article reports on the decision of a U.S. court of appeals to lift a lower court injunction suspending federal funding for grants and contracts involving human embryonic stem cell (hESC) research.

  • FROM THE HILL.  // Issues in Science & Technology;Summer2011, Vol. 27 Issue 4, p23 

    The article reports on the science and technology-related issues, polices and regulations in 2011 in the U.S. In a bill signed by President Barack Obama, there are reductions in budgets of several research and development (R&D) programs including defense, nondefense, and energy. A federal...

  • From the editors. Skipper, Magdalena; Casci, Tanita; Flintoft, Louisa // Nature Reviews Genetics;Jul2005, Vol. 6 Issue 7, p515 

    Focuses on the issue concerning the needed interest for the financing of clinical trials on stem cell research. Success achieved by South Korea and Great Britain in their research on human embryonic stem-cell cloning; Restriction on the funding of stem cell research implemented by the...

  • WEEK IN WASHINGTON.  // BioWorld Insight;10/4/2010, Vol. 18 Issue 40, p6 

    The article offers news briefs in Washington, D.C. including the decision of the U.S. Circuit Court of Appeals for the District of Columbia to stop the enjoinment on the embryonic stem cell research fund, the passage of the Improving Access to Clinical Trials Act and the appointment of Pfizer...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics